Pharmacokinetics of cefepime during continuous venovenous hemodiafiltration

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2424-2427

  Allaouchiche, Bernard ^a   Breilh, Dominique ^b   Jaumain, Hélène ^a   Gaillard, Betty ^b   Renard, Sylvie ^c   Saux, Marie Claude ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; DIALYSATE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0030685785     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2424     Document Type: Article

References (19)

1. Barbhaiya, R. H., S. T. Forgue, C. R. Gleason, C. A. Knupp, K. A. Pittman, D. J. Weidler, and R. R. Martin. 1990. Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses. Antimicrob. Agents Chemother. 34:1118-1122.
2. Barbhaiya, R. H., C. A. Knupp, S. T. Forgue, G. R. Matzke, D. R. Guay, and K. A. Pittman. 1990. Pharmacokinetics of cefepime in subjects with renal insufficiency. Clin. Pharmacol. Ther. 48:268-276.
3. Barbhaiya, R. H., S. T. Forgue, C. R. Gleason, C. A. Knupp, K. A. Pittman, D. J. Weidler, H. Movahhed, J. Tenney, and R. R. Martin. 1992. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects. Antimicrob. Agents Chemother. 36:552-557.
4. Bellomo, R., H. Teede, and N. Boyce. 1993. Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study. Intensive Care Med. 19:329-332.
5. Bressolle, F., J. M. Kinowski, J. E. de la Coussaye, N. Wynn, J. J. Eledjam, and M. M. Galtier. 1994. Clinical pharmacokinetics during continuous haemofiltration. Clin. Pharmacokinet. 26:457-471.
6. Cotterill, S. 1995. Antimicrobial prescribing in patients on haemofiltration. J. Antimicrob. Chemother. 36:773-780.
7. Cunha, B., and M. Gill. 1995. Cefepime. Med. Clin. N. Am. 79:721-732.
8. D'Argenio, D. 1981. Optimal sampling times for pharmacokinetics experiments. J. Pharmacokinet. Biopharm. 9:739-756.
9. Davies, J., J. Kingswood, P. Sharpstone, and M. Street. 1995. Drug removal in continuous haemofiltration and haemodialysis. Br. J. Hosp. Med. 54:524-528.
10. Geronemus, R. P., N. S. Schneider, and M. Epstein. 1991. Survival in patients treated with continuous arteriovenous haemodialysis for acute renal failure and chronic renal failure. Contrib. Nephrol. 93:29-31.
11. Golper, T. A. 1993. Drug removal during continuous renal replacement therapies. Dial. Transplant. 22:185-188.
12. Hancock, R. E., and F. Bellido. 1991. Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins. J. Antimicrob. Chemother. 29:1-6.
13. Hardin, T. C., and T. S. Jennings. 1994. Cefepime. Pharmacotherapy 14: 657-668.
14. Keller, F., H. Wilms, G. Schultze, G. Offerman, and M. Molhazan. 1983. Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysis. Clin. Nephrol. 19:201-205.
15. Kieft, H., A. I. Hoepelman, C. A. Knupp, A. Van Dijk, J. M. Branger, A. Struyvenberg, and J. Verhoef. 1993. Pharmacokinetics of cefepime in patients with the sepsis syndrome. J. Antimicrob. Chemother. 32:117-122.
16. Nikaido, H., W. Liu, and E. Y. Rosenberg. 1990. Outer membrane permeability and β-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents. Antimicrob. Agents Chemother. 34:337-342.
17. Reetze-Bonorden, P., J. Böhler, and E. Keller. 1993. Drug dosage in patients during continuous renal replacement therapy. Clin. Pharmacokinet. 24:362-379.
18. Shetz, M., P. Ferdinande, G. Van den Berghe, C. Verwaest, and P. Lauwers. 1995. Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med. 21:612-620.
19. Tam, P. Y., S. Huraib, B. Mahan, D. LeBlanc, C. A. Lunski, C. Holtzer, C. E. Doyle, S. I. Vas, and P. R. Uldall. 1988. Slow continuous hemodialysis for the management of complicated acute renal failure in an intensive care unit. Clin. Nephrol. 30:79-85.